Cancer - Qualigen Therapeutics, Inc.

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT06086522

A Phase I, Multicenter, Open-label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacodynamics, and Pharmacokinetics of Intravenous QN-302 in Patients with Advanced or Metastatic Solid Tumors

Drug

QN-302

Condition

Advanced or metastatic solid carcinomas